Supplementary Figures S3G–I shows the mean percentages ± SD of CD200+, CD19+, and CD19+/CD200+ CSF-EVs in the rMS, pMS, CIS, OIND, and ONIND groups. Here, CD200 is linked to in situ carcinoma.